1 |
PIÑEIRO R, MARTÍNEZ-PENA I, LÓPEZ-LÓPEZ R.Relevance of CTC clusters in breast cancer metastasis[J]. Adv Exp Med Biol, 2020,1220: 93-115.
|
2 |
KWAK T J, LEE E. In vitro modeling of solid tumor interactions with perfused blood vessels[J]. Sci Rep, 2020, 10(1): 20142.
|
3 |
ESTEVA F J, HUBBARD-LUCEY V M, TANG J, et al. Immunotherapy and targeted therapy combinations in metastatic breast cancer[J].Lancet Oncol, 2019, 20(3): e175-e186.
|
4 |
WATSON M A, FLEMING T P. Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer[J]. Cancer Res, 1996, 56(4): 860-865.
|
5 |
BECKER R M, DARROW C, ZIMONJIC D B, et al. Identification of mammaglobin B, a novel member of the uteroglobin gene family[J]. Genomics, 1998, 54(1): 70-78.
|
6 |
LI C, ZHANG T. Human mammaglobin: a specific marker for breast cancer prognosis[J]. J Buon, 2016, 21(1): 35-41.
|
7 |
ZHANG Y Q, LUN X Q, GUO W L. Expression of TRPC1 and SBEM protein in breast cancer tissue and its relationship with clinicopathological features and prognosis of patients[J]. Oncol Lett, 2020, 20(6): 392.
|
8 |
VALLADARES-AYERBES M, IGLESIAS-DÍAZ P, DÍAZ-PRADO S, et al. Diagnostic accuracy of small breast epithelial mucin mRNA as a marker for bone marrow micrometastasis in breast cancer: a pilot study[J]. J Cancer Res Clin Oncol, 2009, 135(9): 1185-1195.
|
9 |
LIU Z Z, XIE X D, QU S X, et al. Small breast epithelial mucin (SBEM) has the potential to be a marker for predicting hematogenous micrometastasis and response to neoadjuvant chemotherapy in breast cancer[J]. Clin Exp Metastasis, 2010, 27(4): 251-259.
|
10 |
ZISI Z, ADAMOPOULOS P G, KONTOS C K, et al. Identification and expression analysis of novel splice variants of the human carcinoembryonic antigen-related cell adhesion molecule 19 (CEACAM19) gene using a high-throughput sequencing approach[J]. Genomics, 2020, 112(6): 4268-4276.
|
11 |
MICHAELIDOU K, TZOVARAS A, MISSITZIS I, et al. The expression of the CEACAM19 gene, a novel member of the CEA family, is associated with breast cancer progression[J]. Int J Oncol, 2013, 42(5): 1770-1777.
|
12 |
于洪涛, 唐大海. 癌胚抗原相关细胞粘附因子19与乳腺癌相关基因关系[J]. 中国公共卫生, 2016, 32(1): 105-107.
|
13 |
ESTIAR M A, ESMAEILI R, ZARE A A, et al. High expression of CEACAM19, a new member of carcinoembryonic antigen gene family, in patients with breast cancer[J]. Clin Exp Med, 2017, 17(4): 547-553.
|
14 |
孙 凯, 孙 松, 胡恩伟, 等. 联合CK19、hMAM、SBEM检测乳腺癌外周血循环肿瘤细胞及其与分子分型和临床病理特征的相关性分析[J]. 临床和实验医学杂志, 2018, 17(3): 270-273.
|
15 |
LIVAK K J, SCHMITTGEN T D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method[J]. Methods, 2001, 25(4): 402-408.
|
16 |
杨 超, 康 炜, 李建华, 等. 血清乳腺珠蛋白与乳腺癌的相关性及临床意义探讨[J]. 检验医学,2014,29(1): 61-64.
|
17 |
印 滇, 王亚非, 杨 莉, 等. hMAM水平与乳腺癌早期诊断和癌微转移的相关性及临床意义研究[J]. 临床和实验医学杂志, 2015, 14(18): 1512-1515.
|
18 |
GOEDEGEBUURE P S, WATSON M A, VIEHL C T,et al. Mammaglobin-based strategies for treatment of breast cancer[J].Curr Cancer Drug Targets, 2004,4(6): 531-542.
|
19 |
JOUDI F S AL, JOUDI F S A L. Human mammaglobin in breast cancer: a brief review of its clinical utility[J]. Indian J Med Res, 2014, 139(5): 675-685.
|
20 |
HU Y, LIU P, WU D, et al. Prognostic role of plasma mammaglobin A expression in breast carcinoma patients: a meta-analysis[J]. Onco Targets Ther, 2018, 11: 3245-3255.
|
21 |
MIKSICEK R J, MYAL Y, WATSON P H, et al. Identification of a novel breast- and salivary gland-specific, mucin-like gene strongly expressed in normal and tumor human mammary epithelium[J]. Cancer Res, 2002, 62(10): 2736-2740.
|
22 |
尤小兰, 王元杰, 王伟林, 等. 外周血中乳腺上皮小黏蛋白、人乳珠蛋白表达与乳腺癌预后的关系[J]. 中华实验外科杂志, 2014, 31(12): 2825-2827.
|
23 |
HU X H, CHEN M F, LI Y L, et al. Aberrant CEACAM19 expression is associated with metastatic phenotype in penile cancer[J]. Cancer Manag Res, 2019, 11: 715-725.
|
24 |
ZHAO H, XU J, WANG Y, et al. Knockdown of CEACAM19 suppresses human gastric cancer through inhibition of PI3K/Akt and NF-κB[J]. Surg Oncol, 2018, 27(3): 495-502.
|
25 |
ONISHI M, ICHIKAWA T, KUROZUMI K, et al. Angiogenesis and invasion in glioma[J]. Brain Tumor Pathol, 2011, 28(1): 13-24.
|
26 |
于秀艳, 张晓伟, 野丽莉, 等.hMAM联合MMP-9和C-erbB2 mRNA表达检测在乳腺癌外周血微转移诊断中的应用[J]. 吉林大学学报(医学版),2017, 43(5): 1009-1014.
|
27 |
陶 健, 胡明泰, 周 明, 等. 乳腺癌外周血乳腺上皮小黏蛋白和CA153联合检测的临床价值[J]. 中国肿瘤临床与康复, 2017, 24(3): 266-269.
|
28 |
BOZHENKO V K, KHARCHENKO N V, VASKEVICH E F,et al .Mammaglobin in peripheral blood and tumor in breast cancer patients [J].Biomed Khim,2016,62(4):453-457.
|
29 |
邓 君, 郭中晓, 洪 华, 等. 人乳腺珠蛋白基因表达和趋化因子CXCL16及CA153在乳腺癌诊断中的应用[J]. 实用医院临床杂志, 2021, 18(2): 74-76.
|
30 |
温冰馨, 王 斌. 钼靶联合hMAM、BRCA-1表达水平检测对乳腺癌的诊断价值[J]. 检验医学与临床, 2021, 18(4): 482-485.
|
31 |
吴海燕, 何雄斌, 胡玉林, 等. 乳腺癌外周血微转移与乳腺癌转移抑制基因1的相关性及临床意义[J]. 中华内分泌外科杂志, 2018, 12(5): 362-366, 376.
|
32 |
NGUYEN H M, DAO M Q. Detection of human mammaglobin mRNA in breast cancer cells among Vietnamese women[J]. Breast Cancer (Dove Med Press), 2019, 11: 143-150.
|